There is cause for concern regarding public safety since the Drug Testing Laboratory (DTL) has discovered counterfeit medications from seven different pharmaceutical companies. Not only are these items inefficient and perhaps dangerous, but they also include harmful compounds and lack vital active ingredients, as shown during routine testing.
Medications for a variety of ailments, including bacterial infections and anxiety, were found to be counterfeit. A few notable instances are:
East Pharmaceuticals, Lahore, Pakistan, makes Eyosef 250mg capsules, which are used to treat bacterial infections such as those in the urinary or respiratory tracts.
Alcoxime suspension, made in Karachi by Alpine Laboratories, is another medication used to treat bacterial infections.
Menakline Pharma of Karachi produces Milixime suspension, whereas Miraz Pharma of Kasur produces Mirzpan suspension.
The results also highlighted medication for anxiety, such as Porm Pharmaceuticals’ Lexopam tablets and Bromalex, as well as Multicare Pharmaceutical’s Zionex tablets, both manufactured in Karachi.
It was discovered that these medications were made using fictitious business addresses and manufacturing permits. Their lack of essential Active Pharmaceutical Ingredients (API) and their production in filthy, hazardous settings rendered them useless and harmful for human consumption.
Because they may include hazardous compounds or psychotropic chemicals in dangerous amounts, health professionals have cautioned that taking these fake pharmaceuticals could have serious effects. Many times, these unregulated medications make things worse or even put people’s lives in jeopardy.
If we want to stop these dangerous medications from reaching consumers, we need stronger pharmaceutical laws and stricter enforcement, according to scientists and authorities. In light of these disturbing findings, safeguarding public health has become an increasingly pressing concern.
